Company profile: Hydra Biosciences
1.1 - Company Overview
Company description
- Provider of biopharmaceutical drug discovery and development leveraging novel ion channels to develop drugs for pain, inflammation, cardiovascular and other diseases, based in Cambridge, Massachusetts, utilizing proprietary high-throughput screening platforms.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hydra Biosciences
Oxford Global Resources
HQ: United States
Website
- Description: Provider of headhunting, executive search, and specialized recruitment services, matching consultants to roles at Fortune 500 companies and start-ups across Life Sciences, Consumer & Industrial, Technology & Communications, Healthcare, Financial Services & Insurance, and the Public Sector, with one-on-one placement, job search assistance, and project support, including follow-ups and timely payments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Global Resources company profile →
Crelux
HQ: Germany
Website
- Description: Provider of structure-based drug discovery solutions for pharma, biotech, and research organizations, offering protein engineering and production, isotope labeling, custom conjugation, antigen production, structure determination (X-ray crystallography, cryo-EM, NMR), biophysics and biochemistry techniques, fragment-based drug discovery, medicinal chemistry and CADD, and scientific advisory and project management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crelux company profile →
Orgenesis
HQ: United States
Website
- Description: Provider of point-of-care platforms, technologies, and networks to develop, produce, and distribute advanced cell and gene therapies, including a novel diabetes treatment that converts liver cells into functional insulin-producing cells. Offers POCare Platform, Therapies, Technologies, and a global POCare Network to lower costs and accelerate market access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orgenesis company profile →
Clinilabs
HQ: United States
Website
- Description: Provider of clinical drug development services specializing in CNS medications, from first-in-human to Phase 3 trials. Offers global site selection via a network in 42 countries, decentralized trials using telemedicine, electronic tools, remote assessment and wearables, corelab data services to centralize and improve data accuracy, and centralized PSG and EEG capture and analysis for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinilabs company profile →
Argon Network
HQ: United Kingdom
Website
- Description: Provider of an international network of independent healthcare agencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Argon Network company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hydra Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hydra Biosciences
2.2 - Growth funds investing in similar companies to Hydra Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hydra Biosciences
4.2 - Public trading comparable groups for Hydra Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →